Related references
Note: Only part of the references are listed.High CD8(+) and absence of Foxp3(+) T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival
Paula Fluxa et al.
BMC CANCER (2018)
Prognosis of ovarian cancer is associated with effector memory CD8(+) T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
Sonja Lieber et al.
ONCOIMMUNOLOGY (2018)
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
Niki Karachaliou et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
TH2 cell development and function
Jennifer A. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
TH9 cells in anti-tumor immunity
Thaiz Rivera Vargas et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
Rui Deng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Intratumoral FoxP3+Helios+ Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
Azharuddin Sajid Syed Khaja et al.
FRONTIERS IN IMMUNOLOGY (2017)
JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer
Chunwan Lu et al.
ONCOIMMUNOLOGY (2017)
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial
Shuzhen Liu et al.
JAMA ONCOLOGY (2017)
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Frida Ewald Sander et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways
Hongwu Tan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
Jacob S. Bowers et al.
JCI INSIGHT (2017)
Regulatory T cells that co-express RORt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
Stalin Chellappa et al.
ONCOIMMUNOLOGY (2016)
Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response
Kristina Berg Lorvik et al.
CANCER RESEARCH (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Induction of antigen-specific TH9 immunity accompanied by mast cell activation blocks tumor cell engraftment
Aws Abdul-Wahid et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Expression of Th1-Th2-and Th17-associated cytokines in laryngeal carcinoma
Xiaoqun Xu et al.
ONCOLOGY LETTERS (2016)
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
Yinghua Zhao et al.
NATURE COMMUNICATIONS (2016)
Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients
Yumi Nonomura et al.
ONCOIMMUNOLOGY (2016)
Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer
Gautier Stoll et al.
ONCOIMMUNOLOGY (2016)
Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy
Jintong Chen et al.
OncoImmunology (2016)
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
Alexander S. Baras et al.
ONCOIMMUNOLOGY (2016)
PD-1 marks dysfunctional regulatory T cells in malignant gliomas
Daniel E. Lowther et al.
JCI INSIGHT (2016)
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary et al.
VACCINES (2016)
Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type
Joseph Fabre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
Faycal Djenidi et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune cell interplay in colorectal cancer prognosis
Samuel E. Norton et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2015)
The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
S. T. Ward et al.
BRITISH JOURNAL OF CANCER (2015)
Tumor-induced perturbations of cytokines and immune cell networks
Brett Burkholder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy
Jungsun Park et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
Frederique Vegran et al.
NATURE IMMUNOLOGY (2014)
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
Ahmad A. Tarhini et al.
PLOS ONE (2014)
Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers
Yong Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
Hye-Jung Kim et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Pegylated IL-10 induces cancer immunity
John B. Mumm et al.
BIOESSAYS (2013)
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Nicoletta Cieri et al.
BLOOD (2013)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
IL-17 family: Cytokines, receptors and signaling
Chunfang Gu et al.
CYTOKINE (2013)
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor
Wen-Chung Chen et al.
HISTOPATHOLOGY (2013)
Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
C. Andrew Stewart et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC
Chandan Verma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours
Sabine Hoepner et al.
PLOS ONE (2013)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer
Gareth Betts et al.
GUT (2012)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Th9 cells promote antitumor immune responses in vivo
Yong Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
Hiroyuki Tao et al.
LUNG CANCER (2012)
Induction and molecular signature of pathogenic TH17 cells
Youjin Lee et al.
NATURE IMMUNOLOGY (2012)
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells
Rahul Purwar et al.
NATURE MEDICINE (2012)
Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
Nichole R. Blatner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
Jiankun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
FOXP3 and survival in urinary bladder cancer
Malin E. Winerdal et al.
BJU INTERNATIONAL (2011)
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP
Wei Ju et al.
BLOOD (2011)
IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
John B. Mumm et al.
CANCER CELL (2011)
A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment
Gabriele Cantini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Memory Type 2 Helper T Cells Induce Long-Lasting Antitumor Immunity by Activating Natural Killer Cells
Masayuki Kitajima et al.
CANCER RESEARCH (2011)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
Martha L. Slattery et al.
CARCINOGENESIS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
IL-9 Contributes to Immunosuppression Mediated by Regulatory T Cells and Mast Cells in B-Cell Non-Hodgkin's Lymphoma
Li-Li Feng et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
Lucia De Monte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
Cailin M. Wilke et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma
Lin Lv et al.
PLOS ONE (2011)
The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
Shoba Amarnath et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Higher levels of GATA3 predict better survival in women with breast cancer
Nam K. Yoon et al.
HUMAN PATHOLOGY (2010)
Ultrastructural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma
Andrea Modesti et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Human Th17 Cells Comprise Heterogeneous Subsets Including IFN-γ-Producing Cells with Distinct Properties from the Th1 Lineage
Katia Boniface et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-9: Basic Biology, Signaling Pathways in CD4+T Cells and Implications for Autoimmunity
Hongmei Li et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Evaluations of Interferon-γ/Interleukin-4 Ratio and Neutrophil/Lymphocyte Ratio as Prognostic Indicators in Gastric Cancer Patients
Hideyuki Ubukata et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Yi-Lan Zhang et al.
MOLECULAR CANCER (2010)
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Xi Chen et al.
LUNG CANCER (2010)
Up for Mischief? IL-17/Th17 in the tumour microenvironment
E. Maniati et al.
ONCOGENE (2010)
FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma
Andrea Ladanyi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek et al.
BLOOD (2009)
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert et al.
CANCER RESEARCH (2009)
Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
Hanne Krogh Jensen et al.
CLINICAL CANCER RESEARCH (2009)
Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
Frank A. Sinicrope et al.
GASTROENTEROLOGY (2009)
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
Sabine Schreck et al.
HEMATOLOGICAL ONCOLOGY (2009)
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Natalia Martin-Orozco et al.
IMMUNITY (2009)
The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer
Pirus Ghadjar et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients
Jing-Ping Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses
William H. D. Hallett et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma
Kavita M. Dhodapkar et al.
BLOOD (2008)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai et al.
CANCER (2008)
Epitope landscape in breast and colorectal cancer
Neil H. Segal et al.
CANCER RESEARCH (2008)
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
Khalid I. Al-Shibli et al.
CLINICAL CANCER RESEARCH (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
The biological functions of T helper 17 cell effector cytokines in inflammation
Wenjun Ouyang et al.
IMMUNITY (2008)
Multiple roles for CD4(+) T cells in anti-tumor immune responses
Richard Kennedy et al.
IMMUNOLOGICAL REVIEWS (2008)
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures
Marie-Caroline Dieu-Nosjean et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
Th2-mediated anti-tumour immunity: friend or foe?
J. I. Ellyard et al.
TISSUE ANTIGENS (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
Development in motion: Helper T cells at work
Steven L. Reiner
CELL (2007)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells
Yuan Zhou et al.
CYTOKINE (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells
Lin Qiu et al.
BLOOD (2006)
Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma
Michael G. Alexandrakis et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites
Robert M. Anthony et al.
NATURE MEDICINE (2006)
IL-9 expression contributes to the cellular composition in Hodgkin lymphoma
I Glimelius et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients
T Nagato et al.
CLINICAL CANCER RESEARCH (2005)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma
N Konishi et al.
ONCOLOGY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
CD8(+) tumor-infiltrating lymphocytes together with CD4(+) tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
A Fukunaga et al.
PANCREAS (2004)
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
A Böhle et al.
JOURNAL OF UROLOGY (2003)
The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal
J Lieberman
NATURE REVIEWS IMMUNOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Antitumor cytotoxic T-lymphocyte response in human lung carcinoma:: identification of a tumor-associated antigen
F Mami-Chouaib et al.
IMMUNOLOGICAL REVIEWS (2002)
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB1*0401+ patients with renal cell carcinoma or melanoma
T Tatsumi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation
L Gorelik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)
N Porakishvili et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Role of T-bet in commitment of TH1 cells before IL-12-dependent selection
AC Mullen et al.
SCIENCE (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Share Paper
